Drug intelligence / Profile preview

copper diethyldithiocarbamate

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous (as Liposomal Formulation)
01

Overview

Copper diethyldithiocarbamate is a small molecule copper complex formed by chelation of copper(II) ions with diethyldithiocarbamate ligands. It is the active anticancer agent generated from disulfiram in the presence of copper, showing cytotoxic activity against tumor cells via inhibition of the proteasome, specifically targeting the 19S lid of the proteasome. Therapeutically, it is primarily being investigated for anticancer uses, including glioma and leukemia models, where liposomal formulations have increased efficacy and bioavailability in animal studies. Its pharmacological activity is distinct from its precursor disulfiram, and the compound is poorly water-soluble, presenting formulation challenges for therapeutic use[1].

Other names
copper(II) diethyldithiocarbamatediethyldithiocarbamic acid copper saltcupric diethyldithiocarbamatecopper diethyl dithiocarbamatebis(N,N-diethyldithiocarbamate)copper(II) complexCu-DDC complexcopper(2+) diethyldithiocarbamateaccelerator CDC4567-99-1Cu(DDC)2
02

Targets

19S RP (26S proteasome non-ATPase regulatory subunit 12)

Beyond the preview

Go deeper on copper diethyldithiocarbamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on copper diethyldithiocarbamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call